Akèy › Kansè Glann Salivè › New Jersey
Etid klinik pou Kansè Glann Salivè nan New Jersey
3 etid pou Kansè Glann Salivè ap chèche patisipan nan sit nan New Jersey.
Tèks ofisyèl etid la (Anglè)
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05408845Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT04620187VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Englewood Hospital and Medical Center (site 202), Englewood
- Summit Medical Group (site 205), Florham Park
- Atlantic Health System, Morristown Medical Center (site 124), Morristown
Ap rekriteFaz 1/2
Laj 18 a 80 · Tout sèks · Mizajou Dec 11, 2025 · NCT03556228Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.